Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

IQVIA Holdings Inc. IQV

Healthcare  —  Diagnostics & Research
270.37 (4.65) (1.69%) as of 25 Sep
Market cap
$45.3B
P/E
33.3×
S&P 500 Member Revenue Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

IQVIA Holdings Inc. (IQV) EV/EBITDA

As of 25 September 2026, IQVIA Holdings Inc. (IQV) trades at a EV/EBITDA of 17.3×. Over the past ten years it has ranged from 10.4× (June 2016) to 26.0× (June 2021); the current reading is higher than 46% of that period. That is below the Diagnostics & Research industry median of 25.2× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 15.6× 9.16%
FY2024 14.3× (18.09%)
FY2023 17.5× 3.55%
FY2022 16.9× (30.20%)
FY2021 24.2× 9.62%
FY2020 22.1× 7.45%
FY2019 20.5× 15.20%
FY2018 17.8× (0.50%)
FY2017 17.9× (4.86%)
FY2016 18.8× 50.24%

Quarterly

Period EV/EBITDA Change
Jun 2026 13.5× 7.89%
Mar 2026 12.5× (19.89%)
Dec 2025 15.6× 14.94%
Sep 2025 13.6× 11.82%
42 more quarters

Against its own ten years

Low 10.4× High 26.0×
Ten-year median 17.6×
Current reading's percentile 46

EV/EBITDA against peers

Company EV/EBITDA
NTRA Natera, Inc. compare n/m
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 14.1×
IQV IQVIA Holdings Inc. 17.3×
MTD Mettler-Toledo International, Inc. compare 24.9×
IDXX IDEXX Laboratories, Inc. compare 25.6×
A Agilent Technologies, Inc. compare 26.5×
ILMN Illumina, Inc. compare 36.0×
WAT Waters Corporation compare 49.8×
Diagnostics & Research industry median 25.2×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on IQV